Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Julphar
AstraZeneca
Dow
Cerilliant
Cipla
Chinese Patent Office
McKinsey
Cantor Fitzgerald
Chubb
Novartis

Generated: January 21, 2018

DrugPatentWatch Database Preview

Triamcinolone acetonide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for triamcinolone acetonide and what is the scope of triamcinolone acetonide patent protection?

Triamcinolone acetonide
is the generic ingredient in twenty-five branded drugs marketed by Abbvie, Sanofi Aventis Us, Astellas, Ivax Pharms, Delcor Asset Corp, Teva, Solvay, Actavis Mid Atlantic, Alpharma Us Pharms, Ambix, Fougera Pharms, G And W Labs, Glenmark Pharms Ltd, Lupin Atlantis, Morton Grove, Mylan Pharms Inc, Perrigo New York, Pharmaderm, Pharmafair, Taro, Teligent Pharma Inc, Topiderm, Vintage, Crown Labs, Savage Labs, Flexion Theraps Inc, Apothecon, Parnell, Sandoz Inc, Watson Labs, Allergan, Novartis Pharms Corp, Akorn, G And W Labs Inc, Wockhardt, Wockhardt Eu Operatn, Glenmark Pharms, Cmp Pharma Inc, Lyne, Perrigo Israel, Ranbaxy Labs Ltd, Perrigo Uk Finco, and Riconpharma Llc, and is included in one hundred and twenty-two NDAs. There are eight patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Triamcinolone acetonide has ninety-five patent family members in thirty-six countries.

There are fifty-one drug master file entries for triamcinolone acetonide. Eighty-five suppliers are listed for this compound.
Summary for triamcinolone acetonide
Pharmacology for triamcinolone acetonide
Medical Subject Heading (MeSH) Categories for triamcinolone acetonide

US Patents and Regulatory Information for triamcinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Pharms Inc KENALOG triamcinolone acetonide OINTMENT;TOPICAL 011600-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Perrigo New York TRIAMCINOLONE ACETONIDE triamcinolone acetonide OINTMENT;TOPICAL 087356-001 Approved Prior to Jan 1, 1982 AT RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Teva TRIACET triamcinolone acetonide CREAM;TOPICAL 084908-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us NASACORT ALLERGY 24 HOUR triamcinolone acetonide SPRAY, METERED;NASAL 020468-002 Oct 11, 2013 OTC Yes Yes ➤ Subscribe ➤ Subscribe Y ➤ Subscribe
Delcor Asset Corp KENALOG triamcinolone acetonide LOTION;TOPICAL 011602-001 Approved Prior to Jan 1, 1982 DISCN Yes No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Pharms FLUTEX triamcinolone acetonide OINTMENT;TOPICAL 087377-001 Nov 1, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Delcor Asset Corp KENALOG triamcinolone acetonide LOTION;TOPICAL 084343-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Glenmark Pharms TRIAMCINOLONE ACETONIDE triamcinolone acetonide OINTMENT;TOPICAL 208320-001 Aug 22, 2017 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
G And W Labs TRIAMCINOLONE ACETONIDE triamcinolone acetonide CREAM;TOPICAL 089798-001 May 31, 1991 AT RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Pharms FLUTEX triamcinolone acetonide CREAM;TOPICAL 085539-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for triamcinolone acetonide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us NASACORT ALLERGY 24 HOUR triamcinolone acetonide SPRAY, METERED;NASAL 020468-002 Oct 11, 2013 ➤ Subscribe ➤ Subscribe
Abbvie AZMACORT triamcinolone acetonide AEROSOL, METERED;INHALATION 018117-001 Apr 23, 1982 ➤ Subscribe ➤ Subscribe
Abbvie AZMACORT triamcinolone acetonide AEROSOL, METERED;INHALATION 018117-001 Apr 23, 1982 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us NASACORT ALLERGY 24 HOUR triamcinolone acetonide SPRAY, METERED;NASAL 020468-002 Oct 11, 2013 ➤ Subscribe ➤ Subscribe
Delcor Asset Corp KENALOG-H triamcinolone acetonide CREAM;TOPICAL 086240-001 Approved Prior to Jan 1, 1982 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us NASACORT triamcinolone acetonide AEROSOL, METERED;NASAL 019798-001 Jul 11, 1991 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us NASACORT ALLERGY 24 HOUR triamcinolone acetonide SPRAY, METERED;NASAL 020468-002 Oct 11, 2013 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Non-Orange Book US Patents for triamcinolone acetonide

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,555,047 Corticosteroids for the treatment of joint pain ➤ Subscribe
7,122,206 Aqueous-based pharmaceutical composition ➤ Subscribe
6,375,984 Aqueous-based pharmaceutical composition ➤ Subscribe
Patent No. Title Estimated Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for triamcinolone acetonide

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Fuji
Moodys
QuintilesIMS
Merck
Cipla
US Department of Justice
Chubb
Medtronic
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot